Kencur's Antimicrobial Properties and Oral Wound-Healing Research

Two genuinely separate bodies of research sit under this page's title. One is old and thin: scattered antibacterial screening of kencur rhizome against a handful of bacteria, going back to 2003. The other is recent, concentrated, and almost entirely unmentioned on the main Kencur page: a 2022–2024 research program, mostly out of Thai and Indonesian pharmaceutical-science faculties, isolating specific compounds from kencur rhizome and formulating them into mouth gels for oral ulcers and stomatitis, with real animal and cell-culture efficacy data behind it — including one study where a kencur extract outperformed a standard steroid comparator. This page also documents a case worth reading carefully: a paper whose title promises antimicrobial activity for kencur but whose own results credit two different plants tested alongside it.

Table of Contents

  1. Two Separate Bodies of Evidence Under One Roof
  2. The Direct Antibacterial Testing
  3. A Paper Whose Title Oversells Kencur's Role
  4. Computational Docking Is Not a Laboratory Result
  5. The Oral Mucosal Ulcer Research Program: Isopimarane Diterpenes
  6. From Compound to Product: Formulating a Mucoadhesive Gel
  7. The One Real Animal Efficacy Trial: Beating a Steroid Comparator
  8. An Older, Classic Wound-Healing Study
  9. What "Antimicrobial" Does Not Mean for a Kitchen Spice
  10. Practical Guidance: Cooking Versus Products
  11. Key Research Papers
  12. Connections

Two Separate Bodies of Evidence Under One Roof

It is worth separating these two literatures from the start, because conflating them would overstate both. The first is direct antibacterial and antifungal screening: testing whether a kencur extract, in a dish, slows the growth of specific bacteria. This work is real but modest — a handful of studies, several decades old, usually testing kencur as one of several plants in a broader screen rather than as the focus. The second is a genuinely active, recent, and much more developed program: isolating specific anti-inflammatory and wound-healing compounds from kencur rhizome and building them into topical mouth-gel products for oral ulcers, complete with cell-culture efficacy testing, animal models, and pharmaceutical formulation and stability data. The second body of work is where most of the substance in this article lives.

Back to Table of Contents

The Direct Antibacterial Testing

Three studies test kencur rhizome or its named compounds directly against bacteria:

Back to Table of Contents

A Paper Whose Title Oversells Kencur's Role

One 2024 paper is worth discussing at length precisely because a reader relying on its title alone would draw the wrong conclusion about kencur. Amil and colleagues published "Antimicrobial and Antiproliferative Effects of Zingiberaceae Oils: A Natural Solution for Oral Health" — a title that names the whole ginger family, ginger's botanical family, as delivering antimicrobial benefit for oral health. Kencur was indeed one of four Zingiberaceae species tested (alongside three Curcuma species: mango ginger, Javanese turmeric, and Curcuma aeruginosa).

Reading the actual results, not just the title: the significant antibacterial activity the study reports against oral bacteria — Streptococcus mitis, S. sanguinis, and S. mutans, the primary cavity-causing species — belongs specifically to Javanese turmeric oil and mango ginger oil. Kencur's own essential oil is not named among the extracts producing meaningful inhibition zones in the results. Kencur's role in this study, based on the composition analysis, was chiefly as the source of ethyl-cinnamate (the second constituent identified, after Javanese turmeric's beta-curcumene) — a chemical-profiling data point, not a demonstrated antibacterial contribution.

This matters as more than a technicality. If this study were cited casually as "Zingiberaceae oils, including kencur, show antimicrobial effects for oral health," it would be crediting kencur with a result that, on the paper's own data, belongs to two different plants in the same family tested alongside it — the same kind of substitution error that recurs across herbal-evidence writing generally, just one genus-level rather than one species-level. It is included here, rather than silently dropped, precisely so a reader who encounters this paper's title elsewhere has the actual result to check it against.

Back to Table of Contents

Computational Docking Is Not a Laboratory Result

One further antimicrobial-adjacent paper deserves a clear evidence-tier label rather than being folded in with the laboratory studies above. A 2025 study ran in-silico (computer-simulated) molecular docking of two kencur essential-oil compounds, gamma-elemene and caryophyllene, against two named Staphylococcus aureus biofilm-forming proteins, predicting favorable binding based on modeled molecular geometry and energy calculations.

This is the weakest evidence tier that appears anywhere in this Benefits set, and it is worth explaining exactly why: a docking study never touches a live bacterium, a cell culture, or an animal. It is a prediction, generated entirely inside software, about whether a molecule's three-dimensional shape is compatible with a protein's binding pocket. Docking studies are useful for generating hypotheses that then get tested in an actual dish or animal — they are not themselves evidence that the predicted interaction produces any real biological effect, and a meaningful fraction of computationally-promising docking predictions fail when actually tested in the wet lab. No such follow-up laboratory test of these two compounds against live S. aureus biofilm has yet been published.

Back to Table of Contents

The Oral Mucosal Ulcer Research Program: Isopimarane Diterpenes

This is the real center of gravity for this page: a coherent, multi-year research program, chiefly from Prince of Songkla University in Thailand, isolating specific diterpene compounds from kencur rhizome and testing their wound-healing and anti-inflammatory activity for oral mucosal ulcers — the mouth sores and stomatitis that affect roughly a quarter of the global population at some point, including as a side effect of chemotherapy and radiotherapy.

All three studies are in-vitro cell-culture work, not animal or human trials, and all three come from formulation-science and pharmacognosy laboratories whose explicit goal is eventually producing a marketable topical product — worth knowing as context, though it does not itself invalidate the cell-culture results, which are real, specific, and reasonably consistent across the three related studies.

Back to Table of Contents

From Compound to Product: Formulating a Mucoadhesive Gel

A companion 2024 study by Wahyuni and colleagues addressed a more practical question: not whether kencur's compounds are biologically active, but whether kencur extract can actually be formulated into a stable, usable oral-care gel. Using the whole ethanolic rhizome extract (with EPMC and total polyphenol content confirmed present by HPLC, at concentrations of roughly 1,200–1,850 mg/kg depending on formulation strength), they tested several gelling agents and found Carbopol 934 produced the most physically stable preparation across 14 days of storage, outperforming three commercial oral-care gel products on stability testing. A 30-person sensory panel rated the 5% extract formulation the most acceptable for taste, smell, and feel.

This is a real and useful pharmaceutical-formulation result — it establishes that a kencur-based oral gel is technically feasible and tolerated by a small human panel for basic sensory acceptance — but it should not be mistaken for a clinical efficacy trial. A sensory-acceptance panel measures whether people find a product pleasant to use, not whether it heals an ulcer faster than a placebo. The same research group's own earlier paper, discussed next, states plainly that formal human clinical trials of this material have not yet been conducted.

Back to Table of Contents

The One Real Animal Efficacy Trial: Beating a Steroid Comparator

The strongest single efficacy result in this entire article comes from Wahyuni and colleagues' earlier 2022 study, and it deserves to be reported clearly rather than buried among the cell-culture work above, because it is a genuine animal efficacy trial with a real drug comparator, not just a cell-culture activity assay.

Thirty-five rats were divided into seven groups: untreated normal controls, untreated ulcer controls, a group treated with triamcinolone acetonide (the actual conventional steroid therapy used clinically for oral mucosal ulceration), and four groups treated with different concentrations of ethanol extract of kencur rhizome (EEKG), after all ulcer groups had oral mucosal ulcers induced with 70% acetic acid. Recovery was measured by ulcer-area percentage, a clinical inflammation sign score, and microscopic histopathology.

The 0.5% EEKG dose was more effective than the triamcinolone acetonide comparator on percent ulcer-area recovery and inflammation-sign score, and doses of 0.5–2% EEKG reduced the histopathological damage score. The study's own stated conclusion was appropriately cautious: that kencur "is very potential to be developed as a prospective phytopharmaceutical for the treatment of oral mucosal ulceration in human after clinical trials" — the researchers' own words make clear that no such trial had yet happened. One rat study, however striking the steroid comparison, is not equivalent to a clinical trial, and beating one specific steroid at one specific dose in one specific animal model is not the same claim as "as effective as steroid treatment" in general use.

Back to Table of Contents

An Older, Classic Wound-Healing Study

Predating the Thai oral-ulcer research program by over a decade, Tara Shanbhag and colleagues (2006) tested alcoholic kencur extract in three separate classic wound-healing models in Wistar rats — incision wounds (measuring breaking strength), excision wounds (measuring the rate of wound contraction and re-epithelialization), and dead-space wounds (measuring granulation tissue formation) — both alone and alongside dexamethasone, a steroid known to impair wound healing as a side effect.

Kencur extract alone significantly increased wound-breaking strength, sped up epithelialization, and increased wound contraction. More interesting mechanistically: when co-administered with dexamethasone, kencur extract significantly reversed dexamethasone's wound-healing-impairing effect on all three measures. That reversal-of-a-known-drug-effect design is a more informative test than a simple untreated-versus-treated comparison, because it demonstrates the extract is doing something specific to the wound-healing process rather than merely reflecting some general difference between animal groups. It remains, like everything else on this page, animal data.

Back to Table of Contents

What "Antimicrobial" Does Not Mean for a Kitchen Spice

It is worth doing the arithmetic on what these MIC (minimum inhibitory concentration) values actually require, because "antimicrobial activity" sounds like a stronger claim in prose than the numbers support in practice. The strongest MIC reported anywhere in this article — kencur's 25 micrograms per milliliter against H. pylori, discussed in full on the digestive health page — describes a concentration of purified extract bathing bacteria directly in a laboratory dish. Reaching an equivalent concentration throughout, say, the stomach lining of a person eating a few grams of kencur in a peanut-sauce dressing would require an amount of extracted, concentrated active compound many times beyond what a culinary serving delivers, before accounting for digestion, absorption, and the fact that a kitchen preparation is mostly water and rice, not concentrated rhizome extract. None of the antibacterial or antifungal findings in this article were designed to establish, or do establish, a dose at which eating kencur meaningfully changes the bacterial population anywhere in a person's body.

Back to Table of Contents

Practical Guidance: Cooking Versus Products

Kencur used as a kitchen spice — in sambal, peanut sauce, or the traditional sha jiang dipping sauce — carries none of the concentration needed for any antimicrobial or wound-healing effect described above, and there is no reason to avoid it on safety grounds; it is simply flavor, with a long culinary track record. A homemade kencur poultice or topical paste for a minor scrape has weak, mostly indirect support (the older wound-healing rat data, plus the general safety profile) and low realistic risk for intact skin, though it is not a substitute for proper wound care on anything beyond a trivial injury, and should never be applied to a deep, infected, or non-healing wound without medical assessment. A commercial kencur-based mouth gel, if one becomes available outside the research literature, sits on genuinely the most developed evidence in this article — real isolated compounds, real cell-culture and one real animal efficacy result — but still short of the human clinical trial its own researchers say is the next necessary step; treat marketing claims for any such product with that gap specifically in mind.

Back to Table of Contents

Key Research Papers

  1. Wahyuni IS, Sufiawati I, Nittayananta W, Levita J. Anti-inflammatory activity and wound healing effect of Kaempferia galanga L. rhizome on the chemical-induced oral mucosal ulcer in Wistar rats. Journal of Inflammation Research, 2022;15:2281–2294. — PubMed
  2. Wahyuni IS, Sufiawati I, Shafuria A, Nittayananta W, Levita J. Formulation and evaluation of mucoadhesive oral care gel containing Kaempferia galanga extract. Pharmaceutics, 2024;16(3):421. — PubMed
  3. Pathan N, Iadnut A, Tewtrakul S. Anti-inflammatory and wound healing effects of mouth gel containing kaempulchraol K from Kaempferia galanga rhizomes. Journal of Ethnopharmacology, 2024;324:117762. — PubMed
  4. Iadnut A, Sae-Lee T, Tewtrakul S. Wound healing potential of mouth gel containing isopimarane diterpene from Kaempferia galanga rhizomes for treatment of oral stomatitis. PeerJ, 2024;12:e18716. — PubMed
  5. Sudsai T, Tungcharoen P, Tewtrakul S. Wound healing properties of pharmaceutical gel containing isopimarane diterpene isolated from Kaempferia galanga L. Journal of Ethnopharmacology, 2022;289:115052. — PubMed
  6. Tara Shanbhag V, Chandrakala S, Sachidananda A, Kurady BL, Smita S, Ganesh S. Wound healing activity of alcoholic extract of Kaempferia galanga in Wistar rats. Indian Journal of Physiology and Pharmacology, 2006;50(4):384–390. — PubMed
  7. Wang Q, Ye J, Wang W. Study of bacteriostasis of kaempferide on foodborne pathogenic bacteria by indirect determination of capillary electrophoresis. Electrophoresis, 2025;46(19):1471–1478. — PubMed
  8. Mekseepralard C, Kamkaen N, Wilkinson JM. Antimicrobial and antioxidant activities of traditional Thai herbal remedies for aphthous ulcers. Phytotherapy Research, 2010;24(10):1514–1519. — PubMed
  9. Sini S, Malathy NS. Antimicrobial properties of roots of medicinal plants. Ancient Science of Life, 2005;25(2):62–65. — PubMed
  10. Amil MA, Rahman SNSA, Yap LF, et al. Antimicrobial and antiproliferative effects of Zingiberaceae oils: a natural solution for oral health (positive results attributable to Curcuma xanthorrhiza and C. mangga, not Kaempferia galanga). Chemistry & Biodiversity, 2024;21(3):e202301836. — PubMed
  11. In-silico molecular docking and molecular dynamic simulation of gamma-elemene and caryophyllene from Kaempferia galanga L. essential oil against Staphylococcus aureus biofilm proteins (computational prediction only, no laboratory confirmation). 2025. — PubMed

Back to Table of Contents

Connections

Back to Table of Contents